Patents Assigned to Neomics Co., Ltd.
  • AIMP2-DX2 gene and its uses
    Patent number: 8431393
    Abstract: The present invention relates to a variant of AIMP2 lacking exon 2 gene, named as AIMP2-DX2 gene, which is specifically expressed in cancer cells. The AIMP2-DX2 gene and siRNA targeting AIMP2-DX2 can be successfully used in the development of diagnosis and treatment of cancer.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: April 30, 2013
    Assignee: Neomics Co., Ltd.
    Inventors: Sunghoon Kim, Jin Woo Choi
  • AIMP2-DX2 gene and SiRNA targeting AIMP2-DX2
    Patent number: 8003780
    Abstract: The present invention relates to a variant of AIMP2 lacking exon 2 gene, named as AIMP2-DX2 gene, which is specifically expressed in cancer cells. The AIMP2-DX2 gene and siRNA targeting AIMP2-DX2 can be successfully used in the development of diagnosis and treatment of cancer.
    Type: Grant
    Filed: October 22, 2008
    Date of Patent: August 23, 2011
    Assignee: Neomics Co., Ltd.
    Inventors: Sunghoon Kim, Jin Woo Choi
  • AIMP2-DX2 Gene and its Uses
    Publication number: 20110136119
    Abstract: The present invention relates to a variant of AIMP2 lacking exon 2 gene, named as AIMP2-DX2 gene, which is specifically expressed in cancer cells.
    Type: Application
    Filed: January 21, 2011
    Publication date: June 9, 2011
    Applicant: Neomics Co., Ltd.
    Inventors: Sunghoon Kim, Jin Woo Choi
  • Antibody Specific to the AIMP2-DX2
    Publication number: 20110117572
    Abstract: The present invention relates to a variant of AIMP2 lacking exon 2 gene, named as AIMP2-DX2 gene, which is specifically expressed in cancer cells.
    Type: Application
    Filed: January 21, 2011
    Publication date: May 19, 2011
    Applicant: Neomics Co., Ltd.
    Inventors: Sunghoon Kim, Jin Woo Choi